Literature DB >> 29164277

High prevalence of dengue antibodies and the arginine variant of the FcγRIIa polymorphism in asymptomatic individuals in a population of Minas Gerais State, Southeast Brazil.

Anna Carolina Toledo da Cunha Pereira1, Tatiane Ribeiro de Siqueira2, Andressa Anunciação de Oliveira Prado3, Camila Almeida Veiga da Silva3, Thaís de Fátima Silva Moraes4, Alan Alex Aleixo5, José Carlos de Magalhaes4, Gabriel Augusto Pires de Souza3, Betânia Paiva Drumond2,6, Gustavo Portela Ferreira1, Breno de Mello Silva7,8, Cintia Lopes de Brito Magalhães7,8, Luciana Lara Santos5, Jaqueline Maria Siqueira Ferreira5, Luiz Cosme Cotta Malaquias3, Luiz Felipe Leomil Coelho9.   

Abstract

Dengue is the most prevalent arthropod-borne viral illness in humans worldwide. Single-nucleotide polymorphisms (SNPs) in genes involved in the immune response, such as dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN), IgG Fc receptor II-A (FcγRIIa), vitamin D receptor (VDR), and tumor necrosis factor alpha (TNF-α), were previously reported to be associated with susceptibility to dengue disease in different human populations. Therefore, due to the relevant association of host immune and genetic status with disease susceptibility/severity of dengue, this work aims to verify the frequency of anti-dengue virus antibodies and some dengue-associated risk SNPs in a population in Minas Gerais State, Southeast Brazil. A total of 1560 individuals were genotyped for polymorphisms in DC-SIGN (rs4804803), FcγRIIa (rs1801274), VDR (rs7975232), and TNF-α (rs1800629). The presence of anti-dengue antibodies (IgM and/or IgG) in these samples was also assayed. Anti-dengue antibodies were detected at an overall frequency of 16.86%, indicating a virus infection in asymptomatic individuals. The genotypic frequencies of all SNPs studied did not differ between the asymptomatic and control groups. Regarding the allelic frequencies of the four SNPs analyzed, a higher frequency was detected of the G allele of FcγRIIa/rs1801274 in the asymptomatic individuals when compared to that in the control group (p = 0.03). Therefore, the results showed a high prevalence of asymptomatic individuals in Minas Gerais State, with a potential association between the presence of the G allele of FcγRIIa/rs1801274 and protection against symptomatic disease.

Entities:  

Keywords:  Asymptomatic patients; Dengue; FcRγRIIa; SNPs

Mesh:

Substances:

Year:  2017        PMID: 29164277     DOI: 10.1007/s00251-017-1046-y

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  34 in total

Review 1.  Dengue.

Authors:  Scott B Halstead
Journal:  Lancet       Date:  2007-11-10       Impact factor: 79.321

2.  Multiple testing corrections for imputed SNPs.

Authors:  Xiaoyi Gao
Journal:  Genet Epidemiol       Date:  2011-01-19       Impact factor: 2.135

3.  Meta-Analysis of the Relationship between TNF-α (-308G/A) and IL-10 (-819C/T) Gene Polymorphisms and Susceptibility to Dengue.

Authors:  Ana Caroline Melo Dos Santos; Edilson Leite de Moura; Jean Moisés Ferreira; Barbara Rayssa Correia Dos Santos; Verônica de Medeiros Alves; Karol Fireman de Farias; Elaine Virgínia Martins de Souza Figueiredo
Journal:  Immunol Invest       Date:  2016-12-16       Impact factor: 3.657

4.  An epidemiological study of dengue in Delhi, India.

Authors:  Kumar Vikram; B N Nagpal; Veena Pande; Aruna Srivastava; Rekha Saxena; Anup Anvikar; Aparup Das; Himmat Singh; Sanjeev K Gupta; N R Tuli; Olivier Telle; N K Yadav; Neena Valecha; Richard Paul
Journal:  Acta Trop       Date:  2015-10-01       Impact factor: 3.112

5.  Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphism.

Authors:  Gissel García; Beatriz Sierra; Ana B Pérez; Eglys Aguirre; Ileana Rosado; Narjara Gonzalez; Alienys Izquierdo; Maritza Pupo; Didye Ruiz Danay Díaz; Lizet Sánchez; Beatriz Marcheco; Kenji Hirayama; María G Guzmán
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

Review 6.  Dengue hemorrhagic fever and shock syndromes.

Authors:  Suchitra Ranjit; Niranjan Kissoon
Journal:  Pediatr Crit Care Med       Date:  2011-01       Impact factor: 3.624

7.  Asymptomatic humans transmit dengue virus to mosquitoes.

Authors:  Veasna Duong; Louis Lambrechts; Richard E Paul; Sowath Ly; Rath Srey Lay; Kanya C Long; Rekol Huy; Arnaud Tarantola; Thomas W Scott; Anavaj Sakuntabhai; Philippe Buchy
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-09       Impact factor: 11.205

8.  A single amino acid distinguishes the high-responder from the low-responder form of Fc receptor II on human monocytes.

Authors:  M R Clark; S G Stuart; R P Kimberly; P A Ory; I M Goldstein
Journal:  Eur J Immunol       Date:  1991-08       Impact factor: 5.532

9.  DC-SIGN (CD209) Promoter -336 A/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation.

Authors:  Lin Wang; Rong-Fu Chen; Jien-Wei Liu; Ing-Kit Lee; Chiu-Ping Lee; Ho-Chang Kuo; Shau-Ku Huang; Kuender D Yang
Journal:  PLoS Negl Trop Dis       Date:  2011-01-04

Review 10.  Predicting outcome from dengue.

Authors:  Sophie Yacoub; Bridget Wills
Journal:  BMC Med       Date:  2014-09-04       Impact factor: 8.775

View more
  2 in total

Review 1.  Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective.

Authors:  David G Menter; Vahid Afshar-Kharghan; John Paul Shen; Stephanie L Martch; Anirban Maitra; Scott Kopetz; Kenneth V Honn; Anil K Sood
Journal:  Cancer Metastasis Rev       Date:  2022-01-12       Impact factor: 9.237

2.  Integrated vector management with additional pre-transmission season thermal fogging is associated with a reduction in dengue incidence in Makassar, Indonesia: Results of an 8-year observational study.

Authors:  Isra Wahid; Hasanuddin Ishak; Abdul Hafid; Muhammad Fajri; Sukmawati Sidjal; Armin Nurdin; Naisyah Tun Azikin; Rusdyah Sudirman; Hajar Hasan; Muhammad Yusuf; Imam Bachtiar; William A Hawley; Ronald Rosenberg; Neil F Lobo
Journal:  PLoS Negl Trop Dis       Date:  2019-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.